EDGAR Filing Documents for 0001571049-16-020143

Form 424B2 - Prospectus [Rule 424(b)(2)]:

SEC Accession No. 0001571049-16-020143

Filing Date

2016-11-23

Accepted

2016-11-23 16:47:43

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FINAL PROSPECTUS	t1602924_424b2.htm	424B2	612505
2	GRAPHIC	t1602924_logo.jpg	GRAPHIC	27593
3	GRAPHIC	t1602924_p19.jpg	GRAPHIC	42866
	Complete submission text file	0001571049-16-020143.txt		710878

Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059

Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770

Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | Fiscal Year End: 1231
Type: 424B2 | Act: 33 | File No.: 333-214230 | Film No.: 162017117
SIC: 2834 Pharmaceutical Preparations